Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 151 entries
View as:

A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT04230044 Org: User:
Start: 04/11/16 End: 07/03/17 Due: 07/03/18

The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.

Phase: N/A Priority: Normal
NCT ID: NCT00165711 Org: User:
Start: 03/31/03 End: - Due: -

Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

Phase: N/A Priority: Normal
NCT ID: NCT02455271 Org: User:
Start: 10/01/12 End: 12/22/15 Due: 12/22/16

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT01506752 Org: User:
Start: 07/31/11 End: 09/30/11 Due: 09/30/12

A Phase 1 Comparative Study of E2022 Current and New Patch Formulations

Phase: N/A Priority: Normal
NCT ID: NCT02042729 Org: User:
Start: 08/31/12 End: 12/31/12 Due: 12/31/13

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT03059381 Org: User:
Start: 08/01/16 End: 03/21/21 Due: 03/21/22

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01618695 Org: User:
Start: 05/15/12 End: 05/28/20 Due: 05/28/21

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

Phase: N/A Priority: Normal
NCT ID: NCT04238715 Org: User:
Start: 01/22/20 End: 03/31/26 Due: 03/31/27

A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.

Phase: N/A Priority: Normal
NCT ID: NCT02094053 Org: User:
Start: 09/12/13 End: 04/21/17 Due: 04/21/18

Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02175173 Org: User:
Start: 06/13/13 End: 11/02/22 Due: 11/02/23

A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation

Phase: N/A Priority: Normal
NCT ID: NCT01677624 Org: User:
Start: 08/31/12 End: 03/31/14 Due: 03/31/15

A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04683185 Org: User:
Start: 12/28/20 End: 06/21/21 Due: 06/21/22

A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.

Phase: N/A Priority: Normal
NCT ID: NCT04573556 Org: User:
Start: 10/17/20 End: 03/17/22 Due: 03/17/23

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT02423187 Org: User:
Start: 03/17/15 End: 10/30/17 Due: 10/30/18

A Study of E7080 in Subjects With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01268293 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Phase: N/A Priority: Normal
NCT ID: NCT02300532 Org: User:
Start: 01/10/13 End: 03/24/15 Due: 03/24/16

An Study of Efficacy and Safety of Clevudine

Phase: N/A Priority: Normal
NCT ID: NCT01192854 Org: User:
Start: 02/28/10 End: 05/31/11 Due: 05/31/12

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Phase: N/A Priority: Normal
NCT ID: NCT01397448 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT02454478 Org: User:
Start: 07/01/15 End: 05/29/17 Due: 05/29/18

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03780907 Org: User:
Start: 02/14/03 End: 08/06/03 Due: 08/06/04

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02192515 Org: User:
Start: 07/31/14 End: 01/31/16 Due: 01/31/17

A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies

Phase: N/A Priority: Normal
NCT ID: NCT00598650 Org: User:
Start: 02/29/08 End: 03/31/11 Due: 03/31/12

A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)

Phase: N/A Priority: Normal
NCT ID: NCT01774773 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Phase: N/A Priority: Normal
NCT ID: NCT01151540 Org: User:
Start: 11/30/10 End: 08/31/13 Due: 08/31/14

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Phase: N/A Priority: Normal
NCT ID: NCT03201900 Org: User:
Start: 06/28/17 End: 07/27/20 Due: 07/27/21